47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes

被引:60
作者
Domnanich K.A. [1 ,2 ]
Müller C. [3 ,4 ]
Benešová M. [3 ,4 ]
Dressler R. [1 ]
Haller S. [3 ]
Köster U. [5 ]
Ponsard B. [6 ]
Schibli R. [3 ,4 ]
Türler A. [1 ,2 ]
van der Meulen N.P. [1 ,3 ]
机构
[1] Laboratory of Radiochemistry, Paul Scherrer Institut, Villigen-PSI
[2] Department of Chemistry and Biochemistry University of Bern, Bern
[3] Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut, Villigen-PSI
[4] Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich
[5] Institut Laue-Langevin, Grenoble
[6] SCK.CEN, BR2 Reactor, Mol
关键词
!sup]46[!/sup]Ca; !sup]47[!/sup]Sc; !sup]47[!/sup]Ti; Matched pairs; Radionuclide production; SPECT/CT imaging; Theragnostics; Thermal and fast neutrons;
D O I
10.1186/s41181-017-0024-x
中图分类号
学科分类号
摘要
Background: Radiotheragnostics makes use of the same molecular targeting vectors, labeled either with a diagnostic or therapeutic radionuclide, ideally of the same chemical element. The matched pair of scandium radionuclides, 44Sc and 47Sc, satisfies the desired physical aspects for PET imaging and radionuclide therapy, respectively. While the production and application of 44Sc was extensively studied, 47Sc is still in its infancy. The aim of the present study was, therefore, to investigate and compare two different methods of 47Sc production, based on the neutron irradiation of enriched 46Ca and 47Ti targets, respectively. Methods: 47Sc was produced by thermal neutron irradiation of enriched 46Ca targets via the 46Ca(n,γ)47Ca → 47Sc nuclear reaction and by fast neutron irradiation of 47Ti targets via the 47Ti(n,p)47Sc nuclear reaction, respectively. The product was compared with regard to yield and radionuclidic purity. The chemical separation of 47Sc was optimized in order to obtain a product of sufficient quality determined by labeling experiments using DOTANOC. Finally, preclinical SPECT/CT experiments were performed in tumor-bearing mice and compared with the PET image of the 44Sc labeled counterpart. Results: Up to 2 GBq 47Sc was produced by thermal neutron irradiation of enriched 46Ca targets. The optimized chemical isolation of 47Sc from the target material allowed formulation of up to 1.5 GBq 47Sc with high radionuclidic purity (>99.99%) in a small volume (~700 μL) useful for labeling purposes. Three consecutive separations were possible by isolating the in-grown 47Sc from the 46/47Ca-containing fraction. 47Sc produced by fast neutron irradiated 47Ti targets resulted in a reduced radionuclidic purity (99.95–88.5%). The chemical purity of the separated 47Sc was determined by radiolabeling experiments using DOTANOC achievable at specific activities of 10 MBq/nmol. In vivo the 47Sc-DOTANOC performed equal to 44Sc-DOTANOC as determined by nuclear imaging. Conclusion: The production of 47Sc via the 46Ca(n,γ)47Ca nuclear reaction demonstrated significant advantages over the 47Ti production route, as it provided higher quantities of a radionuclidically pure product. The subsequent decay of 47Ca enabled the repeated separation of the 47Sc daughter nuclide from the 47Ca parent nuclide. Based on the results obtained from this work, 47Sc shows potential to be produced in suitable quality for clinical application. © 2017, The Author(s).
引用
收藏
相关论文
共 37 条
[1]  
Bartos B., Majkowska A., Kasperek A., Krajewski S., Bilewicz A., New separation method of no-carrier-added <sup>47</sup>Sc from titanium targets, Radiochim Acta, 100, 7, pp. 457-461, (2012)
[2]  
Baum R.P., Kulkarni H.R., THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience, Theranostics, 2, 5, pp. 437-447, (2012)
[3]  
Bokhari T.H., Mushtaq A., Khan I.U., Separation of no-carrier-added radioactive scandium from neutron irradiated titanium, J Radioanal Nucl Chem, 283, 2, pp. 389-393, (2010)
[4]  
Chakravarty R., Goel S., Valdovinos H.F., Hernandez R., Hong H., Nickles R.J., Cai W., Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with <sup>44</sup>Sc-Labeled Cetuximab Fab Fragment, Bioconjug Chem, 25, 12, pp. 2197-2204, (2014)
[5]  
Chrysanthopoulou N., Savva P., Varvayanni M., Catsaros N., Compilation of Existing Neutron Screen Technology”. Science and Technology of Nuclear Installations, (2014)
[6]  
Domnanich K.A., Muller C., Farkas R., Schmid R.M., Ponsard B., Schibli R., Turler A., Van der Meulen N., <sup>44</sup>Sc for labeling of DOTA- and NODAGA- functionalized peptides: preclinical in vitro and in vivo investigations, EJNMMI Radioanal Chem, 8, 1, (2016)
[7]  
Garcia-Torano E., Peyres V., Roteta M., Sanchez-Cabezudo A.I., Romero E., Martinez Ortega A., Standardisation and precise determination of the half-life of <sup>44</sup>Sc, Appl Radiat Isot, 109, pp. 314-318, (2016)
[8]  
Hernandez R., Valdovinos H.F., Yang Y., Chakravarty R., Hong H., Barnhart T.E., Cai W., <sup>44</sup>Sc: an attractive isotope for peptide-based PET imaging, Mol Pharm, 11, 8, pp. 2954-2961, (2014)
[9]  
Kolsky K.L., Joshi V., Mausner L.F., Srivastava S.C., Radiochemical purification of no-carrier-added Scandium-47 for radioimmunotherapy, Appl Radiat Isot, 49, 12, pp. 1541-1549, (1998)
[10]  
Kraeber-Bodere F., Barbet J., Challenges in nuclear medicine: innovative theranostic tools for personalized medicine, Front Med (Lausanne), 1, (2014)